GSK Sues Pfizer Claiming RSV Vaccine Patent Infringement

August 3, 2023

(CNBC) – GlaxoSmithKline on Wednesday sued Pfizer in U.S. court, alleging patent infringement over Britain-based GSK’s respiratory syncytial virus vaccine.  GSK claims New York-based Pfizer’s RSV vaccine, Abrysvo, infringes on four of its patents related to the antigen used in its own shot. (Read More)